Barclays Downgrades Allscripts (MDRX) to Equalweight
Tweet Send to a FriendGet Alerts MDRX Hot Sheet
Price: $13.89 -0.5%
Rating Summary:
11 Buy, 16 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Rating Summary:
11 Buy, 16 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Trade MDRX Now!
Barclays downgraded Allscripts (NASDAQ: MDRX) from Overweight to Equalweight, price target cut from $23 to $12.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $16.02 yesterday, with a 52 week range of $13.85-$21.92.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $16.02 yesterday, with a 52 week range of $13.85-$21.92.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Raymond James Downgrades Allscripts (MDRX) to Outperform
- BGC Partners Downgrades DuPont (DD) to Sell
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
